Piramal
Bullish Momentum for Piramal Pharma Above 235, Targeting 285+Details:
Asset: Piramal Pharma Limited (PIRAMALPHARMA)
Breakout Level: 235
Potential Target: 285+ with potential for further gains
Stop Loss: Below 235 or as per risk tolerance
Timeframe: Short to medium-term
Rationale: Piramal Pharma has shown strong bullish momentum above the 235 level, and it is now targeting 285. The stock's technical indicators suggest continued strength, positioning it for a further upward move if it sustains this breakout.
Market Analysis:
Technical Setup: Breaking and sustaining above 235 suggests an ongoing bullish trend, with 285 as the immediate target.
Bullish Indicators: Price action above 235 with significant buying volume implies a bullish sentiment that could drive the stock even higher.
Price Target:
The initial target is 285, with room for further gains if momentum continues.
Risk Management:
A stop loss below 235 is recommended to manage risk in case of reversal.
Timeframe:
The move towards 285+ is expected in the short to medium-term, subject to sustained buying pressure and market support.
Risk-Reward Ratio: Favorable, with limited downside below 235 and strong upside potential, making it a bullish setup for near-term gains.
Monitor market trends and volume to confirm sustained bullish momentum and consider the broader market sentiment as you track Piramal Pharma’s movement.
PIRAMAL PHARMAPPL offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries. It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India. In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market.
Piramal Pharma Solution provides integrated drug discovery, development, and manufacturing services for both drug substances, i.e. active pharmaceutical ingredients (APIs) and drug products, i.e. formulations across the life cycle of a molecule, from discovery and clinical development to commercial launch. In addition, the Company has a joint venture (Allergan India Private Limited) with Allergan (now AbbVie), one of the market leaders in ophthalmology in the Indian formulations market.
The Company is among the leading players in India in the self-care space, with established brands like Saridon, Supradyn, Lacto Calamine, Little's, Tetmosol, i-Pill and Polycrol.
Piramal Enterprises- Breakout Possible 📈 Needs to close above 1114 and stay there for the next stage of accumulation to begin. All levels given on the chart. Follow a strict Stop Loss at 953 or 10% below purchase price for higher safety. 🧿This one has legs....Buyback at 1250 complete by Mr. Piramal. Next up on a fundamental basis would be increasing retail footprint or sale of more ancillary biz to focus on the retail NBFC opportunity. India needs 10 more co's the size of Bajaj Finance to get to where it's going. PEL will be one of them IMO. Long term wealth creator...🥂
Piramal Enterprises - Best swing trade idea📈 Exciting Bullish Pattern Alert! 🐂
📊 Pattern: Falling Channel
📌 Symbol/Asset: PEL
🔍 Description: Stock is around good support where we can clearly see Low of Polarity and Falling channel support.
Well around 810-815 is the strong support because there is a Quarterly low.
We can see good bounce here on.
👉 Disclosure: We are not SEBI registered analysts, this is not a buy or sell recommendation.
Piramal may be a good pickThe stock is trading in a price range for the last five months. This time again at the lower levels. If able to sustain above 780 levels, may be bullish in coming sessions. The buy scenario is open only above 780. Keep it on the radar.
Only for learning and sharing purposes, not a piece of trading advice in any form.
All the best.
Simple Trade Setup | PIRAMAL ENTERPRISE | 18-01-2022 [INTRADAY]NSE:PEL
Observations:
1) On 1 day time, we can see it made trianlge pattern. And also made bullish candle from 100DMA.
100DMA will be immediate support now.
100DMA is placed at 2638.56 level.
Immediate breaout levele is at 2675 level now.
Please refer below chart : 1day Time Frame.
-------------------------------------
Trade Setup for 18-01-2022
1) Don't Jump in to trade at the beginning of the market. Let it get settle for 15-20min first and judge the price action.
2) Everything is mentioned on the chart. I hope it is easy to understand.
3) All the levels will work as support, resistance, entry and exit w.r.t price action near that level.
4) Avoid gap up or gap down chase. Wait and trade between levels.
Please refer below chart for levels.
Hope I made it easy to understand it.
Do comment your doubt or suggestion.
Note: Trade with Strict SL. It may or may not hit all the levels. So one can book profit / loss at respective level considering how price action works near that level.
PIRAMAL ENTERPRISE PEL Short Term ViewsPEL short term views
Short Sell Opportunity in this stocks.
NIFTY is also weak and shorting only after getting rejection from 2500 levels.
Previously that was acting as Support now that becomes Resistance for the trade.
*NOTE
We are not SEBI registered.
Views shared here are for educational purpose.
Before Investing please consult your financial advisor
Piramal Enterprise - Positional view | Potential 66% gainKey Highlights:
1. Bullish market structure - HH, HL
2. Volume expansion
3. Trendline breakout
4. Breakout & retest done
5. Support zone 1527-1624
6. Forming Inverse Head & Shoulder
7. Target: 2225, 2700, 3233. Stop Loss: 1585
8. Time frame: 3-6 months
You are always advised to use an appropriate Risk-Reward ratio as per your strategy.
P.S: This is NOT investment advice. This chart is meant for learning purposes only. Invest your capital at your own risk.
intraday idea for tomorrow #equity pelts gonna be a bullish day for pel. the buy entry point is mentioned in the chart buy above only if it closes above it. targets 1,2,3 are given. stoploss can be placed below trendline. the ideas which iam giving here is meant for educational purpose.if you like my analysis like,share and follow me for daily intraday analysis.
🏥 💊 pel #NIFTYPHARMA #NIFTY #BANKNIFTY long only if you have idea what is reersal id find reversal in this stock then only go long
******whatever charts or levels sharing here are just for educational purpose only not a recommendation. please do your own analysis before taking any trade on them. we are not SEBI registered.